News

CareTrust REIT: One Of My Top REITs Has Crushed The Market, I’m Still Bullish (NYSE:CTRE)

1 Mins read

This article was written by

Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own due diligence. I’m a Navy veteran who enjoys dividend investing in quality blue-chip stocks, BDC’s, and REITs. I am a buy-and-hold investor who prefers quality over quantity and plans to supplement his retirement income and live off dividends in the next 5-7 years. I aspire to reach and help the hard working, lower and middle class workers build investment portfolios of high quality, dividend-paying companies. I also hope to give investors a new perspective to help them reach financial independence.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of ADC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Cidara Therapeutics: Still Big Catalysts Ahead Following Impressive Ph2b Readout (CDTX)

1 Mins read
This article was written by Follow Background: Physician involved in clinical research. Investment style: Clinical-stage biotech stocks, long only, both long-term ideas and event-driven…
News

Galiano Gold Inc. (GAU) Q2 2025 Earnings Call Transcript

1 Mins read
Galiano Gold Inc. (NYSE:GAU) Q2 2025 Earnings Conference Call August 14, 2025 10:30 AM ET Company Participants Matt Badylak – President, CEO…
News

Similarweb Ltd. 2025 Q2 - Results - Earnings Call Presentation (NYSE:SMWB)

1 Mins read
Q2: 2025-08-12 Earnings Summary EPS of $0.01 beats by $0.02  | Revenue of $70.97M (17.03% Y/Y) beats by $2.15M This article was written…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *